Skip to main content
. 2008 Feb 7;9(1):217–223. doi: 10.1208/s12249-008-9036-x

Table II.

Effect of Mometasone Treatments on the Cell Cycle Distribution in A549 Cells

Treatment Percent cells
G0/G1 phase G2/M phase S phase
Untreated 70 ± 1.3 5 ± 0.5 24 ± 2.5
Blank NP 70 ± 0.9 4 ± 1.0 26 ± 1.9
MF 76 ± 1.5 12 ± 1.2 10 ± 0.4
MF-NPs 80 ± 0.6 11 ± 0.8 9 ± 0.2
WGA-MF-NPs 84 ± 0.6 11 ± 0.5 5 ± 0.4

(Mean ± S.D., n = 3)

Blank NP Blank nanoparticles; MF mometasone furoate; MF-NPs mometasone furoate nanoparticles; WGA-MF-NPs WGA conjugated mometasone furoate nanoparticles